A 67-Year-Old Woman with ER+ PR+ Breast Cancer

Kevin Kalinsky, MD, MS, presents a case of ER-positive/PR-positive breast cancer and highlights the prevalence of cases such as this in the United States.

Criteria used by breast oncologists to risk stratify patients who present with HR-positive breast cancer.

The rationale for treating patients with early-stage HR-positive breast cancer with abemaciclib and endocrine therapy.

An overview of CDK4/6 inhibitors available for patients with advanced or metastatic HR-positive breast cancer, and recommendations for managing common adverse events associated with therapy.

Guidance on how to treat a 67-year-old patient with ER-positive/PR-positive breast cancer, and additional therapies in the pipeline that have the potential to improve treatment.